- Home
- ALBT
as 10-17-2024 4:00pm EST
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | FREEHOLD |
| Market Cap: | 3.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 195.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.16 - $1.44 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Avalon GloboCare Corp. News
ALBT Breaking Stock News: Dive into ALBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
9 days ago
Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device
MT Newswires
2 months ago
Top Midday Gainers
MT Newswires
2 months ago
Avalon's Laboratory Services to Launch Sales of Catheter Device; Shares Soar
GlobeNewswire
2 months ago
Avalon’s Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device
Benzinga
2 months ago
EXCLUSIVE: Avalon's Lab Services MSO Poised To Commercialize FDA-Registered External Male Catheter Device
GlobeNewswire
3 months ago
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
GlobeNewswire
3 months ago
Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us
GlobeNewswire
4 months ago
Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference
Compare ALBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALBT Avalon GloboCare Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.